vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and WATSCO INC (WSO). Click either name above to swap in a different company.
WATSCO INC is the larger business by last-quarter revenue ($1.5B vs $962.7M, roughly 1.6× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs 6.1%, a 1.7% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 0.1%). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -15.3%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Watsco, Inc. is a distributor of air conditioning, heating and refrigeration equipment, and related parts and supplies (HVAC/R) in the United States. Watsco was founded more than 60 years ago as a manufacturer of parts, components, and tools used in the HVAC/R industry. In 1989, the company shifted from manufacturing to distribution, by acquiring Gemaire Distributors Inc., a South Florida-based Rheem distributor.
ATR vs WSO — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $1.5B |
| Net Profit | $74.3M | $92.9M |
| Gross Margin | — | 27.9% |
| Operating Margin | 11.0% | 7.2% |
| Net Margin | 7.7% | 6.1% |
| Revenue YoY | 13.5% | 0.1% |
| Net Profit YoY | -26.4% | -1.7% |
| EPS (diluted) | $1.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.5B | ||
| Q4 25 | $962.7M | $1.6B | ||
| Q3 25 | $961.1M | $2.1B | ||
| Q2 25 | $966.0M | $2.1B | ||
| Q1 25 | $887.3M | $1.5B | ||
| Q4 24 | $848.1M | $1.8B | ||
| Q3 24 | $909.3M | $2.2B | ||
| Q2 24 | $910.1M | $2.1B |
| Q1 26 | — | $92.9M | ||
| Q4 25 | $74.3M | $71.7M | ||
| Q3 25 | $127.9M | $161.6M | ||
| Q2 25 | $111.7M | $183.6M | ||
| Q1 25 | $78.8M | $80.1M | ||
| Q4 24 | $100.9M | $96.8M | ||
| Q3 24 | $100.0M | $171.0M | ||
| Q2 24 | $90.5M | $181.4M |
| Q1 26 | — | 27.9% | ||
| Q4 25 | — | 27.1% | ||
| Q3 25 | — | 27.5% | ||
| Q2 25 | — | 29.3% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 26.7% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 27.1% |
| Q1 26 | — | 7.2% | ||
| Q4 25 | 11.0% | 6.4% | ||
| Q3 25 | 14.2% | 11.4% | ||
| Q2 25 | 14.9% | 13.2% | ||
| Q1 25 | 12.8% | 7.3% | ||
| Q4 24 | 14.2% | 7.8% | ||
| Q3 24 | 15.2% | 11.6% | ||
| Q2 24 | 13.8% | 12.6% |
| Q1 26 | — | 6.1% | ||
| Q4 25 | 7.7% | 4.5% | ||
| Q3 25 | 13.3% | 7.8% | ||
| Q2 25 | 11.6% | 8.9% | ||
| Q1 25 | 8.9% | 5.2% | ||
| Q4 24 | 11.9% | 5.5% | ||
| Q3 24 | 11.0% | 7.9% | ||
| Q2 24 | 9.9% | 8.5% |
| Q1 26 | — | — | ||
| Q4 25 | $1.13 | $1.82 | ||
| Q3 25 | $1.92 | $3.98 | ||
| Q2 25 | $1.67 | $4.52 | ||
| Q1 25 | $1.17 | $1.93 | ||
| Q4 24 | $1.48 | $2.42 | ||
| Q3 24 | $1.48 | $4.22 | ||
| Q2 24 | $1.34 | $4.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $392.7M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $3.2B |
| Total Assets | $5.3B | $4.6B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $392.7M | ||
| Q4 25 | $409.5M | $733.3M | ||
| Q3 25 | $264.8M | $524.3M | ||
| Q2 25 | $169.8M | $293.0M | ||
| Q1 25 | $136.8M | $431.8M | ||
| Q4 24 | $226.2M | $781.9M | ||
| Q3 24 | $327.9M | $550.0M | ||
| Q2 24 | $223.9M | $424.9M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $361.6M | ||
| Q3 25 | $546.0M | $340.8M | ||
| Q2 25 | $535.1M | $338.7M | ||
| Q1 25 | $561.2M | $346.4M | ||
| Q4 24 | $688.1M | $337.2M | ||
| Q3 24 | $822.7M | $321.0M | ||
| Q2 24 | $681.5M | $307.1M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | $2.7B | $2.8B | ||
| Q3 25 | $2.8B | $2.8B | ||
| Q2 25 | $2.7B | $2.8B | ||
| Q1 25 | $2.5B | $2.7B | ||
| Q4 24 | $2.5B | $2.7B | ||
| Q3 24 | $2.5B | $2.7B | ||
| Q2 24 | $2.4B | $2.6B |
| Q1 26 | — | $4.6B | ||
| Q4 25 | $5.3B | $4.4B | ||
| Q3 25 | $5.1B | $4.6B | ||
| Q2 25 | $4.9B | $4.7B | ||
| Q1 25 | $4.5B | $4.5B | ||
| Q4 24 | $4.4B | $4.5B | ||
| Q3 24 | $4.6B | $4.5B | ||
| Q2 24 | $4.5B | $4.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | 0.13× | ||
| Q3 25 | 0.20× | 0.12× | ||
| Q2 25 | 0.20× | 0.12× | ||
| Q1 25 | 0.22× | 0.13× | ||
| Q4 24 | 0.28× | 0.13× | ||
| Q3 24 | 0.32× | 0.12× | ||
| Q2 24 | 0.28× | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | — |
| Free Cash FlowOCF − Capex | $96.9M | — |
| FCF MarginFCF / Revenue | 10.1% | — |
| Capex IntensityCapex / Revenue | 9.0% | — |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | $399.8M | ||
| Q3 25 | $177.6M | $354.9M | ||
| Q2 25 | $126.0M | $-7.4M | ||
| Q1 25 | $82.7M | $-177.6M | ||
| Q4 24 | $178.2M | $378.9M | ||
| Q3 24 | $229.3M | $232.8M | ||
| Q2 24 | $143.6M | $57.7M |
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | $388.5M | ||
| Q3 25 | $114.3M | $346.1M | ||
| Q2 25 | $62.5M | $-14.3M | ||
| Q1 25 | $25.9M | $-185.2M | ||
| Q4 24 | $112.2M | $370.9M | ||
| Q3 24 | $162.7M | $223.0M | ||
| Q2 24 | $75.4M | $51.3M |
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | 24.6% | ||
| Q3 25 | 11.9% | 16.7% | ||
| Q2 25 | 6.5% | -0.7% | ||
| Q1 25 | 2.9% | -12.1% | ||
| Q4 24 | 13.2% | 21.1% | ||
| Q3 24 | 17.9% | 10.3% | ||
| Q2 24 | 8.3% | 2.4% |
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 0.7% | ||
| Q3 25 | 6.6% | 0.4% | ||
| Q2 25 | 6.6% | 0.3% | ||
| Q1 25 | 6.4% | 0.5% | ||
| Q4 24 | 7.8% | 0.5% | ||
| Q3 24 | 7.3% | 0.5% | ||
| Q2 24 | 7.5% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | 5.57× | ||
| Q3 25 | 1.39× | 2.20× | ||
| Q2 25 | 1.13× | -0.04× | ||
| Q1 25 | 1.05× | -2.22× | ||
| Q4 24 | 1.77× | 3.91× | ||
| Q3 24 | 2.29× | 1.36× | ||
| Q2 24 | 1.59× | 0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
WSO
Segment breakdown not available.
